| Symbol | BJDX |
|---|---|
| Name | BLUEJAY DIAGNOSTICS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 360 MASSACHUSETTS AVENUE,SUITE 203, ACTON, Massachusetts, 01720, United States |
| Telephone | +1 844 - 327-7078 |
| Fax | — |
| — | |
| Website | https://www.bluejaydx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Bluejay Diagnostics Inc develops, manufactures and markets innovative clinical diagnostic products that improve the quality of medical diagnoses by developing Point-of-Care tests that provide convenience, timeliness, compliance and low cost to physicians and patients in areas where timeliness of the initial triage assessment has a high impact on course of treatment. Additional info from NASDAQ: |
New Form PRE 14A - Bluejay Diagnostics, Inc. <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001213900-26-045587 <b>Size:</b> 7 MB
Read more(85% Positive) BLUEJAY DIAGNOSTICS, INC. (BJDX) Announces Enrollment Update for outcomes Due to Patient Enrollment Issues, Regulatory Process
Read moreBluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial
Read more(99% Neutral) BLUEJAY DIAGNOSTICS, INC. (BJDX) Announces Business Combination
Read more(99% Neutral) BLUEJAY DIAGNOSTICS, INC. (BJDX) Provides Update on intended for critical care conditions
Read moreBluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting
Read moreNew Form SCHEDULE 13D - Bluejay Diagnostics, Inc. <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0001213900-26-025973 <b>Size:</b> 60 KB
Read moreNew Form SCHEDULE 13D - Bluejay Diagnostics, Inc. <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0001213900-26-025962 <b>Size:</b> 60 KB
Read moreNew Form SCHEDULE 13D - Bluejay Diagnostics, Inc. <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0001213900-26-025920 <b>Size:</b> 60 KB
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07425587 | Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study | — | Sepsis, Septic Shock | Not_Yet_Recruiting | 2026-04-12 | 2026-12-30 | ClinicalTrials.gov |
| NCT06654895 | Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study | — | Sepsis, Septic Shock | Recruiting | 2024-11-12 | 2026-08-30 | ClinicalTrials.gov |
| NCT06181604 | Multicenter Symphony IL-6 Monitoring Sepsis ICU Study | — | Sepsis | Completed | 2024-01-12 | 2024-07-12 | ClinicalTrials.gov |
| NCT05665153 | Symphony IL-6 Study in Patients at Risk of Severe Sepsis | — | Severe Sepsis | Recruiting | 2022-11-22 | 2024-11-21 | ClinicalTrials.gov |
| NCT05048888 | Symphony IL-6 Reference Range Study | — | Sepsis | Unknown | 2021-08-31 | 2024-03-30 | ClinicalTrials.gov |
| NCT05048927 | Symphony IL-6 Cutoff Validation Study for Patients at Risk of Severe Sepsis | — | Severe Sepsis | Unknown | 2021-08-31 | 2024-12-31 | ClinicalTrials.gov |
| NCT05060250 | Symphony IL-6 Cutoff Establishment Study for Patients at Risk of Severe Sepsis … | — | Severe Sepsis | Unknown | 2021-08-31 | 2024-12-31 | ClinicalTrials.gov |